Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTNNB1 | P35222 | 7/20 | 0.49 |
| ▸ | MMP2 | P08253 | 2/20 | 0.47 |
| ▸ | MMP3 | P08254 | 2/20 | 0.44 |
| ▸ | CASP1 | P29466 | 2/20 | 0.43 |
| ▸ | MMP8 | P22894 | 1/20 | 0.41 |
| ▸ | CCKBR | P32239 | 1/20 | 0.41 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | CTSB | P07858 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7411011 | 0.91 | MMP3 (0.53) | CTNNB1MMP2MMP3CASP1MMP8 | |
| SCHEMBL7414032 | 0.89 | CASP1 (0.47) | CTNNB1MMP2MMP3CASP1 | |
| SCHEMBL7408170 | 0.88 | CASP1 (0.47) | CTNNB1MMP2MMP3CASP1MMP8 | |
| SCHEMBL7406669 | 0.88 | MMP3 (0.51) | CTNNB1MMP2MMP3CASP1MMP8 | |
| SCHEMBL7410916 | 0.87 | MMP3 (0.46) | CTNNB1MMP2MMP3CASP1MMP8 | |
| SCHEMBL7411432 | 0.85 | CTSB (0.45) | CTNNB1MMP2MMP3CASP1MMP8 | |
| SCHEMBL7411983 | 0.82 | CTNNB1 (0.46) | CTNNB1MMP3CASP1CCKBR | |
| SCHEMBL7406317 | 0.82 | MMP3 (0.48) | CTNNB1MMP2MMP3CASP1MMP8 | |
| SCHEMBL7411007 | 0.82 | CASP1 (0.45) | CTNNB1MMP2MMP3CASP1MMP8 | |
| SCHEMBL7408148 | 0.81 | MMP3 (0.44) | CTNNB1MMP2MMP3CASP1MMP8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2002076968-A1 | MALONATES AS INHIBITORS OF THE ICE/CED-6 FAMILY OF CYSTEINE PROTEASES | NOVARTIS AG (CH) | 2002-10-03 | — | — | WO | disclosed |